George Kirov

Author PubWeight™ 133.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007 12.62
2 Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010 12.27
3 Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008 10.52
4 Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008 10.49
5 Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009 6.13
6 Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet 2012 3.50
7 Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry 2013 3.01
8 A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry 2013 2.93
9 Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry 2005 2.58
10 A genome-wide association study for late-onset Alzheimer's disease using DNA pooling. BMC Med Genomics 2008 2.20
11 Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry 2006 2.16
12 Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry 2010 2.11
13 Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Hum Genet 2002 2.03
14 Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. Am J Psychiatry 2011 1.94
15 De novo rates and selection of schizophrenia-associated copy number variants. Biol Psychiatry 2011 1.87
16 Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006 1.61
17 Phenotypic variations on the theme of CNVs. Nat Genet 2008 1.58
18 Family aggregation of high myopia: estimation of the sibling recurrence risk ratio. Invest Ophthalmol Vis Sci 2004 1.50
19 Copy number variation in schizophrenia in the Japanese population. Biol Psychiatry 2009 1.49
20 Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry 2005 1.48
21 A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet 2007 1.43
22 Effects of chronic lithium treatment on renal function. J Affect Disord 2010 1.43
23 Population structure and genome-wide patterns of variation in Ireland and Britain. Eur J Hum Genet 2010 1.39
24 The Bipolar Affective Disorder Dimension Scale (BADDS)--a dimensional scale for rating lifetime psychopathology in bipolar spectrum disorders. BMC Psychiatry 2004 1.38
25 Linkage analysis of the genetic loci for high myopia on 18p, 12q, and 17q in 51 U.K. families. Invest Ophthalmol Vis Sci 2004 1.29
26 Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophr Res 2011 1.28
27 An international collaborative family-based whole-genome linkage scan for high-grade myopia. Invest Ophthalmol Vis Sci 2009 1.25
28 Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc Natl Acad Sci U S A 2006 1.25
29 Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biol Psychiatry 2008 1.20
30 Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2006 1.19
31 CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Hum Mol Genet 2013 1.14
32 Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures. Hum Mol Genet 2013 1.11
33 Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biol Psychiatry 2005 1.10
34 Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry 2004 1.10
35 Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 2009 1.08
36 Strong evidence that GNB1L is associated with schizophrenia. Hum Mol Genet 2007 1.07
37 SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain 2013 1.05
38 Implication of a rare deletion at distal 16p11.2 in schizophrenia. JAMA Psychiatry 2013 1.05
39 P2RX7: A bipolar and unipolar disorder candidate susceptibility gene? Am J Med Genet B Neuropsychiatr Genet 2009 1.00
40 Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry 2006 1.00
41 Genetic differences between five European populations. Hum Hered 2010 0.98
42 SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. J Neurol 2014 0.95
43 De novo mutation in schizophrenia. Schizophr Bull 2012 0.95
44 Localization of bipolar susceptibility locus by molecular genetic analysis of the chromosome 12q23-q24 region in two pedigrees with bipolar disorder and Darier's disease. Am J Psychiatry 2005 0.92
45 Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata. Eur J Hum Genet 2011 0.92
46 Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin. Nat Genet 2004 0.90
47 Age-at-onset in bipolar-I disorder: mixture analysis of 1369 cases identifies three distinct clinical sub-groups. J Affect Disord 2008 0.90
48 Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia. J Biomed Biotechnol 2009 0.89
49 A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk. Hum Mol Genet 2012 0.89
50 Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. Am J Med Genet 2002 0.88
51 No association between the putative functional ZDHHC8 single nucleotide polymorphism rs175174 and schizophrenia in large European samples. Biol Psychiatry 2005 0.88
52 Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping. BMC Psychiatry 2008 0.88
53 Schizophrenia two-hit hypothesis in velo-cardio facial syndrome. Am J Med Genet B Neuropsychiatr Genet 2013 0.86
54 Reduced burden of very large and rare CNVs in bipolar affective disorder. Bipolar Disord 2013 0.86
55 The effectiveness of electroconvulsive therapy in treatment-resistant depression: a naturalistic study. J ECT 2008 0.86
56 Analysis of ProDH, COMT and ZDHHC8 risk variants does not support individual or interactive effects on schizophrenia susceptibility. Schizophr Res 2006 0.86
57 Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples. Am J Med Genet B Neuropsychiatr Genet 2009 0.83
58 The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy. J ECT 2006 0.83
59 Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population. J Affect Disord 2009 0.83
60 Mosaic copy number variation in schizophrenia. Eur J Hum Genet 2013 0.81
61 Relative suppression of magical thinking: a transcranial magnetic stimulation study. Cortex 2007 0.81
62 Sequence analysis of 17 NRXN1 deletions. Am J Med Genet B Neuropsychiatr Genet 2013 0.80
63 Mood-incongruent psychosis in bipolar disorder: conditional linkage analysis shows genome-wide suggestive linkage at 1q32.3, 7p13 and 20q13.31. Bipolar Disord 2009 0.80
64 Fine-mapping reveals novel alternative splicing of the dopamine transporter. Am J Med Genet B Neuropsychiatr Genet 2010 0.80
65 Linkage disequilibrium mapping of bipolar affective disorder at 12q23-q24 provides evidence for association at CUX2 and FLJ32356. Am J Med Genet B Neuropsychiatr Genet 2005 0.79
66 Four years of successful maintenance electroconvulsive therapy. J ECT 2009 0.78
67 Absence of de novo point mutations in exons of GRIN2B in a large schizophrenia trio sample. Schizophr Res 2012 0.78
68 Analysis of neurogranin (NRGN) in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2011 0.77
69 Genetics of epilepsy: epilepsy research foundation workshop report. Epileptic Disord 2007 0.77
70 Genetic variation in the seven-pass transmembrane cadherin CELSR1: lack of association with schizophrenia. Psychiatr Genet 2003 0.76
71 Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation. Psychiatr Genet 2016 0.76
72 Whole-genome-wide association study in the Bulgarian population reveals HHAT as schizophrenia susceptibility gene. Psychiatr Genet 2013 0.76
73 Non-random mating, parent-of-origin, and maternal-fetal incompatibility effects in schizophrenia. Schizophr Res 2012 0.76
74 Underpowered repetitive transcranial magnetic stimulation might not be an effective antidepressant treatment. J Clin Psychiatry 2005 0.75
75 Creativity and mental disorder. Br J Psychiatry 2012 0.75
76 Transcranial magnetic stimulation for patients with depression. Nurs Stand 2005 0.75
77 Major psychiatric disorders and the serotonin transporter gene (SLC6A4): family-based association studies. Psychiatr Genet 2002 0.75
78 Electroconvulsive Therapy Reverses Cerebral Hypoperfusion in a Patient With Psychotic Depression and Catatonia. J ECT 2022 0.75